In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.

@article{Papaparaskevas2010InVA,
  title={In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.},
  author={Joseph Papaparaskevas and Leonidas S. Tzouvelekis and Athanassios Tsakris and Theodore E Pittaras and Nicholas John Legakis},
  journal={Diagnostic microbiology and infectious disease},
  year={2010},
  volume={66 2},
  pages={187-94}
}
MICs to tigecycline and 12 antimicrobials were performed by microdilution method, against 2423 nonduplicate pathogens recently isolated in 17 Greek hospitals. The Food and Drug Administration (FDA) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria were used comparatively for interpretation of tigecycline MICs. Tigecycline exhibited potent in vitro activity against the majority of the isolates tested. (MIC(90) values of 0.5, 1, 2, 0.125, 1, 0.25, 0.125, and 1 mg/L… CONTINUE READING

From This Paper

Topics from this paper.
12 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…